Keyphrases
Targeted Agents
100%
Radiosynthesis
100%
PARP Inhibitor (PARPi)
100%
Talazoparib
100%
Targeted Radiotherapy
20%
Olaparib
20%
Iodo Derivatives
20%
Bromo Derivatives
20%
Tumor
10%
High Affinity
10%
FDA-approved Drugs
10%
Competitive Binding Assay
10%
Radioligand
10%
Tumor Model
10%
Raclopride
10%
Non-invasive Imaging
10%
Biodistribution Studies
10%
Multiple Steps
10%
DNA Repair Capacity
10%
Tumor Uptake
10%
Tritium
10%
Radiochemical Purity
10%
In Vivo Evaluation
10%
Molar Activity
10%
Racemic Mixture
10%
PC-3
10%
Therapeutic Radionuclides
10%
Rucaparib
10%
Critical Enzymes
10%
Chiral Purity
10%
Pharmacology, Toxicology and Pharmaceutical Science
Talazoparib
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
100%
Fluorine 18
33%
Neoplasm
22%
Olaparib
22%
Biodistribution
11%
Raclopride
11%
Radioligand
11%
Radioisotope
11%
Tumor Model
11%
Tritium
11%
Rucaparib
11%